ARCHIVES

BMS Demands Resignation Of Two ImClone Executives

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Newell Reports Cancer Deaths In Younger Age Groups Dropping

March 18, 1977

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992

Clinical Study Group Proposed To Examine Peer Review System

October 15, 1993

NCI/NTP Studies Found EDB Carcinogenic, But Risk To Human Said Not Conclusive

March 23, 1984

R. Lee Clark Clinic Dedication To Honor M.D. Anderson’s “Architect”

November 13, 1987

BRCA Status Can Guide Ovarian Cancer Treatment

April 25, 2008